Morgans says these small cap ASX healthcare shares are buys with 50% upside

Looking for big returns? Then you might want to look at the small side of the market.

| More on:
a doctor in a white coat makes a heart shape with his hands and holds it over his chest where his heart is placed.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

There could be big returns lurking at the small end of town according to analysts at Morgans.

Here's what it is expecting from these small cap ASX healthcare shares:

Aroa Biosurgery Ltd (ASX: ARX)

The first small cap ASX healthcare share that Morgans is bullish on is Aroa Biosurgery.

The broker highlights that Aroa Biosurgery is a regenerative medicine company engaged in developing, manufacturing, and distributing medical devices for wound and tissue repair. It does this with extracellular matrix (ECM) technology in the United States and internationally.

The company has a range of products. These include Endoform Natural and Endoform Antimicrobia Restorative Bioscaffold for treating acute and chronic wounds; Myriad Matrix, an engineered ECM for soft tissue repair, reinforcement, and complex wounds; Myriad Morcells, a morcellized (powdered) format of Myriad Matrix for soft tissue repair and complex wounds; and Reinforced Bioscaffolds, a surgical product for use in ventral hernia repair and abdominal wall reconstruction.

The broker is positive on Aroa Biosurgergy for a number of reasons. These include its low product price point, manufacturing capacity, and product pipeline. It explains:

Aroa has developed a cost effective technology which is estimated to be 30% cheaper than existing products. Sufficient manufacturing capacity through 2 facilities with enough capacity for $100m sales. ARX have a pipeline of new products through both Oroa and TelaBio supported by strong clinical data, we anticipate further news on Symphony and Enivo products.

Morgans currently has an add rating and $1.57 price target on its shares. This implies potential upside of 54% for this small cap ASX healthcare share over the next 12 months.

Volpara Health Technologies Ltd (ASX: VHT)

Another small cap ASX healthcare share that Morgans is tipping as a buy is Volpara.

It is a digital health company offering an increasingly popular solution that improves clinical decision making for early detection of breast cancer. Morgans notes that its products are approved for sale in key regions and provide objective evidence that can be used by relevant specialists including the woman herself to make informed decisions about further screening.

Its analysts have been impressed with the company's performance, which has been underpinned by a strategy shift. It commented:

VHT continues to focus on the most profitable products and markets as well as focusing on larger value customers in line with their revised strategy. The second consecutive quarter of positive net operating cashflow is ahead of management's guidance for 4Q24. We continue to expect the sales pipeline to grow and remain comfortable in guidance to have sufficient cash on hand to maintain net operating cashflow break-even.

Morgans has an add rating and $1.21 price target on this small cap ASX healthcare share. This implies potential upside of 59% for investors over the next 12 month.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Volpara Health Technologies. The Motley Fool Australia has positions in and has recommended Volpara Health Technologies. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Two lab workers fist pump each other.
Healthcare Shares

Guess which top 100 ASX stock is venturing off to the Nasdaq

Here’s what’s going on with its United States listing plan.

Read more »

Two smiling work colleagues discuss an investment or business plan at their office.
Healthcare Shares

Why 'significant upside remains' for CSL shares

Bell Potter thinks very highly of this world-class stock.

Read more »

ASX share price movement represented by doctor pressing digitised screen with array of icons including one entitled health insurance,
Healthcare Shares

Here's why ASX 200 health insurance shares like Medibank are being trounced today

Investors are feeling a bit sick after the latest update.

Read more »

Three Archer Materials scientists wearing white coats and blue gloves dance together in their lab after making a discovery
Record Highs

Superstar ASX 200 healthcare stock snags record high amid $32 million deal

The second multi-million-dollar deal in less than two weeks.

Read more »

Two happy pharmacists standing together in a pharmacy.
Healthcare Shares

Here's why a leading fund manager is excited by this ASX healthcare share

WAM thinks this stock is capable of producing good returns.

Read more »

A medical specialist holds a red heart connected via technology and artificial intelligence (AI)
Share Gainers

Guess which ASX biotech stock just rocketed 25% on big US news

Here are all the details.

Read more »

A woman reclines in a comfortable chair while she donates blood holding a pumping toy in one hand and giving the thumbs up in the other as she is attached to a medical machine to collect her blood donation.
Healthcare Shares

Fundie bullish on CSL shares after praising the 'special business'

Earnings growth justifies current valuations, these experts say.

Read more »

Shot of a young scientist using a digital tablet while working in a lab.
Healthcare Shares

Guess which ASX 200 healthcare stock is charging higher following FDA update

What is getting investors excited today? Let's find out.

Read more »